Am J Transplant, Volume 19, Suppl 3 Archives - Page 114 of 214 - ATC Abstracts

2019 American Transplant Congress
The Changing Paradigm of Ethics in Uterus Transplantation: A Systematic Review
L. M. Ngaage¹, S. Ike², A. Elegbede³, S. Gebran⁴, C. J. Vercler⁵, F. Liang⁴, E. M. Rada¹, C. Cooney³, R. J. Redett³, Y. M. Rasko¹
¹Division of Plastic Surgery, University of Maryland Medical Center, Baltimore, MD, ²London North West University Healthcare Trust, London, United Kingdom, ³Department of Plastic & Reconstructive Surgery, Johns Hopkins Hospital / University of Maryland Medical Center, Baltimore, MD, ⁴Division of Plastic & Reconstructive Surgery, R Adams Cowley Shock Trauma Center, Baltimore, MD, ⁵Plastic Surgery Section, University of Michigan, Ann Arbor, MI
*Purpose: The first uterus transplantation (UTx) was performed in 2000 and sparked ethical debate. As key milestones are reached (successful human UTx in 2011, and…
2019 American Transplant Congress
Evaluation of Mycophenolate Mofetil Exposure in Renal Transplant Recipients
M. C. Ott¹, S. Mietz², S. Chang³
¹Department of Pharmaceutical Services, Erie County Medical Center, Buffalo, NY, ²Department of Pharmacy, Indiana University Health, Indianapolis, IN, ³Department of Medicine, Jacobs School of Medicine & Biomedical Sciencess, Buffalo, NY
*Purpose: Mycophenolate mofetil (MMF) is the most commonly prescribed immunosuppressant following transplantation in the United States. However, the occurrence of MMF therapy-related adverse events including…
2019 American Transplant Congress
Modeling the Effect of Presumed Consent on Waitlist Candidate Quantities
L. DeRoos¹, W. Marrero¹, M. Lavieri¹, D. Hutton², N. Parikh³
¹Industrial and Operations Engineering, University of Michigan, Ann Arbor, MI, ²School of Public Health, University of Michigan, Ann Arbor, MI, ³Department of Internal Medicine, University of Michigan, Ann Arbor, MI
*Purpose: Organ transplantation is a life-saving and cost-effective treatment for patients with end-organ failure. However, the current supply of donors is unable to match demand,…
2019 American Transplant Congress
Evaluating Hepatitis C Treatment after Solid Organ Transplantation
A. J. Burgos¹, R. Yau¹, C. Tunwar², J. A. Goss³, S. Khaderi³, N. L. Sussman⁴
¹Pharmacy, CHI St. Luke's Health-Baylor St. Luke's Medical Center, Houston, TX, ²CHI St. Luke's Health-Baylor St. Luke's Medical Center, Houston, TX, ³Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX, ⁴Abdominal Transplant & Liver Disease, Baylor College of Medicine, Houston, TX
*Purpose: There is limited data on the use of direct acting antivirals for hepatitis C virus (HCV) in the solid organ transplant (SOT) population. The…
2019 American Transplant Congress
Correlation between Gene Expression and Cardiac Function in Ex Vivo Perfused Porcine Hearts
S. Rotich, N. Herbers, S. Hatami, J. Nagendran, M. Mengel, D. Freed, B. Adam
University of Alberta, Edmonton, AB, Canada
*Purpose: Cardiac transplantation is a life-saving intervention for advanced heart failure but it is limited by a shortage of suitable donor organs. Ex vivo heart…
2019 American Transplant Congress
Impact of Glycemic Control on Long Term Graft and Patient Outcomes after Pancreas Transplantation
V. S. Rohan¹, K. Soliman¹, V. Kalbhavi², S. N. Nadig¹, A. Lin¹, V. Rao¹, D. Taber¹
¹Transplant Surgery, Medical University of South Carolina, Charleston, SC, ²Central Michigan University, Mount Pleasant, MI
*Purpose: Successful pancreas transplantation (PTX) has been demonstrated to be efficacious in improving quality of life, eliminating diabetic complications and potentially curing diabetes. However, the…
2019 American Transplant Congress
Should Preceding Solo-Kidney Transplantation for Patients with Type 1 Diabetes with End Stage Renal Failure Be Carried Out?
T. Ito, T. Kenmochi, K. Kurihara, A. Kawai, N. Aida
Transplantation and Regenerative Medicine, Fujita Health University, School of Medicine., Aichi, Japan
*Purpose: Patients with type 1 diabetes with end stage renal failure are indicated for SPK, but if the family requests a renal donation and living…
2019 American Transplant Congress
Immunosuppressant Adherence in Adult Heart Transplant Recipients: An Analysis of Pharmacy Claims and Organ Procurement and Transplantation Network Data
W. S. Cherikh¹, A. R. Wilk¹, J. Maghirang¹, E. A. Witt², H. Kirkham³, S. Boghani², N. Hira⁴, G. Pietradoni², D. K. Klassen¹
¹United Network for Organ Sharing, Richmond, VA, ²Walgreens Co, Deerfield, IL, ³Walgreens Co, Deerfied, IL, ⁴AllianceRx Walgreens Prime, Orlando, FL
*Purpose: The current study was conducted to determine characteristics that are associated with immunosuppressant (IS) medication adherence among adult recipients of deceased donor heart transplants…
2019 American Transplant Congress
Correlation between Self-Reported Medication Adherence and Side Effects in Cardiothoracic Transplant Recipients
T. Harrison¹, N. Patel¹, H. Corbo¹, K. Foster¹, H. Meadows¹, N. Pilch¹, C. Perez¹, J. Fleming¹, D. Judge², L. Paoletti³, D. Taber¹
¹Pharmacy Services, Medical University of South Carolina, Charleston, SC, ²Cardiology, Medical University of South Carolina, Charleston, SC, ³Pulmonary & Critical Care Medicine, Medical University of South Carolina, Charleston, SC
*Purpose: Medication non-adherence (MNA) is a major risk factor for acute rejection and graft loss. It is unclear how medication side effects (SE) and perceived…
2019 American Transplant Congress
Sirolimus in Geriatric Kidney Transplantation: Modification of Outcomes by Pre-Transplant History of Malignancy or Cardiovascular Disease
H. Ibrahim¹, C. Chen², K. Alquadan³, X. Wen⁴, K. L. Womer³, A. H. Santos Jr¹
¹College of Medicine, Div. of Nephrology, Hypertension & Renal Transplantation, Univ. of Florida, Gainesville, FL, ²College of Pharmacy, Univ. of Florida, Gainesville, FL, ³College of Medicine, Div. of Nephrology, Hypertension & Renal Transplantation, Univ. of Florida, Gainesville, FL, ⁴College of Pharmacy, Univ. of Rhode Island, Kingston, RI
*Purpose: We analyzed the outcomes associated with sirolimus (SRL)-regimens in geriatric (>/=65-year-old) kidney transplant recipients (KTRs).*Methods: Using 2000-2016 Scientific Registry of Transplant Recipients data, Cox…